Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
Kardigan fashions $254M series B for late-stage pipeline
The raise brings the biotech's total financing to more than half a billion dollars as data readouts for three licensed cardio assets loom.
Darren Incorvaia
Oct 14, 2025 9:00am
BMS-backed Dispatch unveils with $216M, Carl June as cofounder
Jul 23, 2025 6:30am
Novartis inks $175M option deal for Sironax’s BBB tech
Jul 9, 2025 10:29am
AN Venture Partners raises $200M to boost Japan biotech industry
Jul 2, 2025 11:45am
Arch-backed tRNA biotech shutters after viewing preclinical data
Mar 18, 2025 10:15am
Arbor sails into rocky gene editing waters with $74M
Mar 18, 2025 6:30am
